Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Fresenius Medical Care AG (FMS) over the last 17 years, with Sep 2025 value amounting to $2.1 billion.

  • Fresenius Medical Care AG's Cash & Current Investments rose 12.01% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 12.01%. This contributed to the annual value of $1.7 billion for FY2024, which is 4.31% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Cash & Current Investments stood at $2.1 billion for Q3 2025, which was down 14.49% from $2.5 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Cash & Current Investments ranged from a high of $2.5 billion in Q2 2025 and a low of $1.1 billion during Q2 2022.
  • In the last 3 years, Fresenius Medical Care AG's Cash & Current Investments had a median value of $1.7 billion in 2023 and averaged $1.7 billion.
  • Per our database at Business Quant, Fresenius Medical Care AG's Cash & Current Investments tumbled by 39.04% in 2022 and then skyrocketed by 60.96% in 2025.
  • MRQ analysis of 5 years shows Fresenius Medical Care AG's Cash & Current Investments stood at $1.7 billion in 2021, then dropped by 8.62% to $1.6 billion in 2022, then grew by 15.84% to $1.8 billion in 2023, then dropped by 3.79% to $1.7 billion in 2024, then grew by 22.52% to $2.1 billion in 2025.
  • Its Cash & Current Investments stands at $2.1 billion for Q3 2025, versus $2.5 billion for Q2 2025 and $1.6 billion for Q1 2025.